As of 2025-02-19, the Relative Valuation of Oramed Pharmaceuticals Inc (ORMP) is 2.11 USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.40 USD, the upside of Oramed Pharmaceuticals Inc based on Relative Valuation is -12.1%.
The range of the Relative Valuation is 1.66 - 2.63 USD.
Range | Selected | |
Trailing P/E multiples | 17.4x - 23.7x | 19.8x |
Forward P/E multiples | 17.1x - 24.2x | 20.8x |
Fair Price | 1.66 - 2.63 | 2.11 |
Upside | -30.8% - 9.4% | -12.1% |
Date | P/E |
2025-02-14 | 21.67 |
2025-02-13 | 22.12 |
2025-02-12 | 22.30 |
2025-02-11 | 23.47 |
2025-02-10 | 19.59 |
2025-02-07 | 19.59 |
2025-02-06 | 19.95 |
2025-02-05 | 19.77 |
2025-02-04 | 19.77 |
2025-02-03 | 19.50 |
2025-01-31 | 20.22 |
2025-01-30 | 19.86 |
2025-01-29 | 20.31 |
2025-01-28 | 20.31 |
2025-01-27 | 20.22 |
2025-01-24 | 20.49 |
2025-01-23 | 20.76 |
2025-01-22 | 20.85 |
2025-01-21 | 20.76 |
2025-01-17 | 20.58 |
2025-01-16 | 20.94 |
2025-01-15 | 21.13 |
2025-01-14 | 21.31 |
2025-01-13 | 21.31 |
2025-01-10 | 21.58 |
2025-01-08 | 21.49 |
2025-01-07 | 21.85 |
2025-01-06 | 22.12 |
2025-01-03 | 22.03 |
2025-01-02 | 21.76 |
2024-12-31 | 21.85 |
2024-12-30 | 21.04 |
2024-12-27 | 21.40 |
2024-12-26 | 21.31 |
2024-12-24 | 21.49 |
2024-12-23 | 21.49 |
2024-12-20 | 21.40 |
2024-12-19 | 22.48 |
2024-12-18 | 21.67 |
2024-12-17 | 21.22 |
2024-12-16 | 21.58 |
2024-12-13 | 22.30 |
2024-12-12 | 22.48 |
2024-12-11 | 22.21 |
2024-12-10 | 22.66 |
2024-12-09 | 22.75 |
2024-12-06 | 21.67 |
2024-12-05 | 22.66 |
2024-12-04 | 22.75 |
2024-12-03 | 22.21 |